Page last updated: 2024-09-03

imatinib mesylate and Epulides, Giant Cell

imatinib mesylate has been researched along with Epulides, Giant Cell in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Blatt, J; Fan, Z; Foreman, AKM; McKay, C; Padilla, RJ; Tallent, B	1
de Lange, J; van den Akker, HP; van den Berg, H; van Rijn, RR	1
de Lange, J; van den Akker, HP; van den Berg, H	1

Reviews

1 review(s) available for imatinib mesylate and Epulides, Giant Cell

Article	Year
Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 104, Issue:5 Topics: Adrenal Cortex Hormones; Age Distribution; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Calcitonin; Denosumab; Giant Cell Tumor of Bone; Granuloma, Giant Cell; Humans; Imatinib Mesylate; Interferons; Jaw Diseases; Osteoprotegerin; Piperazines; Pyrimidines; RANK Ligand; Subgingival Curettage	2007

Article

Year

Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 104, Issue:5

Topics: Adrenal Cortex Hormones; Age Distribution; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Calcitonin; Denosumab; Giant Cell Tumor of Bone; Granuloma, Giant Cell; Humans; Imatinib Mesylate; Interferons; Jaw Diseases; Osteoprotegerin; Piperazines; Pyrimidines; RANK Ligand; Subgingival Curettage

2007

Other Studies

2 other study(ies) available for imatinib mesylate and Epulides, Giant Cell

Article	Year
Response of Central Giant Cell Granuloma of the Jaw to Imatinib. Journal of pediatric hematology/oncology, 2023, Jul-01, Volume: 45, Issue:5 Topics: Cherubism; Child; Diagnosis, Differential; Granuloma, Giant Cell; Humans; Imatinib Mesylate; Tomography, X-Ray Computed	2023
Regression of central giant cell granuloma by a combination of imatinib and interferon: a case report. The British journal of oral & maxillofacial surgery, 2009, Volume: 47, Issue:1 Topics: Adolescent; Antineoplastic Agents; Benzamides; Calcitonin; Collagen Diseases; Drug Combinations; Female; Granuloma, Giant Cell; Humans; Imatinib Mesylate; Interferon alpha-2; Interferon-alpha; Mandibular Diseases; Piperazines; Polyethylene Glycols; Pyrimidines; Recombinant Proteins; Remission Induction; Syndrome	2009

Article

Year

Response of Central Giant Cell Granuloma of the Jaw to Imatinib.

Journal of pediatric hematology/oncology, 2023, Jul-01, Volume: 45, Issue:5

Topics: Cherubism; Child; Diagnosis, Differential; Granuloma, Giant Cell; Humans; Imatinib Mesylate; Tomography, X-Ray Computed

2023

Regression of central giant cell granuloma by a combination of imatinib and interferon: a case report.

The British journal of oral & maxillofacial surgery, 2009, Volume: 47, Issue:1

Topics: Adolescent; Antineoplastic Agents; Benzamides; Calcitonin; Collagen Diseases; Drug Combinations; Female; Granuloma, Giant Cell; Humans; Imatinib Mesylate; Interferon alpha-2; Interferon-alpha; Mandibular Diseases; Piperazines; Polyethylene Glycols; Pyrimidines; Recombinant Proteins; Remission Induction; Syndrome

2009